facebook

The Established Safety of AFSTYLA

AFSTYLA safety was evaluated in the largest hemophilia A clinical trial to date with 258 participants

ZERO INHIBITORS

ZERO inhibitors were observed in 258 previously treated children, adolescents, and adults over 19,545 exposure days.

14 of 258 participants reported a side effect

One person withdrew due to a side effect (allergic reaction).

Most common side effects

SIDE EFFECTSSS

Get your free AFSTYLA Discovery Kit

Sign up today!

Sign-up now
You are now leaving the current website.

Do you want to continue?

No Yes